This Study is a multicenter, non-interventional, observational, ambispective (retrospective-prospective) study to evaluate clinical and demographic characteristics, approaches to therapy in outpatients with COPD and frequent exacerbations in the Russian Federation. Planned number of Study site is 35 outpatient centers with experience of treatment of COPD with frequency exacerbations in about 30 regions in Russia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To describe the baseline Demographic data characterisics of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Negative lifestyle factors characterisics of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Anthropometry data characterisics of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline COPD drug treatment duration in previous 52 weeks of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Cardiovascular diseases of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline other comorbidities of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline Blood eosinophils count of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline mean smoking index .
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline mean duration of smoking
Timeframe: 52 weeks of retrospective data before visit 1
To describe the Proportion of patients with overweight
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline dosages of COPD drug treatment in previous 52 weeks of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline proportion of patients with heart failure of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline data of LVEF of patients with heart failure of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline proportion of patients with each CKD stage - C1, C2, C3a, C3b, C4, C5 of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline mean office BP (SBP and DBP) measured at Visit 1 of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline proportion of patients with AH by distribution by AH stage (I, II, III), AH degree (1st, 2nd, 3rd) and risk category at Visit 1 of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1
To describe the baseline proportion of patients with various classes of medications used for treatment of CVD of outpatients with moderate and severe COPD.
Timeframe: 52 weeks of retrospective data before visit 1